Financial Gravity Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$446 1932
2023
Q4
$467 Buy
12
+6
+100% +$221 ﹤0.01% 1164
2023
Q3
$209 Sell
6
-35
-85% -$1.36K ﹤0.01% 944
2023
Q2
$2.47K Buy
41
+2
+5% +$82 0.01% 606
2023
Q1
$246 Sell
39
-5
-11% -$206 0.01% 584
2022
Q4
$984 Sell
44
-128
-74% -$5.39K 0.01% 672
2022
Q3
$271 Sell
172
-52
-23% -$2.66K 0.01% 496
2022
Q2
$354 Sell
224
-24
-10% -$1.42K 0.01% 439
2022
Q1
$394 Sell
248
-1,567
-86% -$95.9K 0.01% 440
2021
Q4
$4.45K Buy
1,815
+1,738
+2,257% +$90.7K 0.1% 222
2021
Q3
$53K Buy
77
+13
+20% +$772 0.03% 542
2021
Q2
$69K Sell
64
-17
-21% -$1.3K 0.02% 466
2021
Q1
$6.25K Sell
81
-2
-2% -$184 0.13% 131
2020
Q4
$8K Buy
+83
New +$10.2K 0.01% 195
2020
Q2
Sell
-738
Closed -$144K 361
2020
Q1
$144K Sell
738
-387
-34% -$83.3K 0.45% 28
2019
Q4
$207K Sell
1,125
-681
-38% -$126K 0.14% 112
2019
Q3
$276K Sell
1,806
-539
-23% -$88.3K 0.24% 83
2019
Q2
$302K Sell
2,345
-602
-20% -$71.4K 0.25% 93
2019
Q1
$344K Buy
+2,947
New +$297K 0.28% 82
2018
Q3
$225K Buy
2,261
+883
+64% +$93.3K 0.24% 97
2018
Q2
$149K Buy
1,378
+333
+32% +$32.3K 0.14% 162
2018
Q1
$96K Buy
+1,045
New +$113K 0.1% 191

Other funds holding LKFT

Financial Gravity Asset Management's LKFT Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 12 shares — an estimated $446 sold.

Financial Gravity Asset Management first reported a position in LKFT in Q1 2018 and held it in 21 quarters. The position peaked at $344K in Q1 2019. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 12 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $446.
  • Financial Gravity Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 21 quarters.
  • Financial Gravity Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $344K in Q1 2019.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.